黄芪治疗急性脑梗塞的前瞻性研究  

A prospective,pilot study of Astragus in the treatment of acute cerebral infarction

作　　者：柴耀辉[1] 秦震[1] 姚景莉[1] 

机构地区：[1]上海医科大学神经病学研究所

出　　处：《临床神经病学杂志》1994年第4期216-218,共3页Journal of Clinical Neurology

摘　　要：５９例经ＣＴ证实的急性脑梗塞病人，在起病后４８小时内随机接受低分子右旋糖酐和在此基础上加用黄芪治疗，比较两组疗效。黄蔑组在各个时点上神经功能缺损的平均减少分数均略优于对照组，但两组差别无显著性。进行亚型分析时发现黄芪对病情中型组和发病后２１小时内开始治疗者有效，差别有显著性。值得扩大样本开展更早期研究。AbstractFor observing clinical effects of Astragus,59 cases of acute cerebral infarction ,confirmed by CT scan,were randomly assigned to receive low molecular dextran or Astragus combining with low molecular dextran within 48hours of stroke onset,The results showed that there was a trend in favor of the treated group in the mean decreased scores of neurologic defecits by repeated ne uro-logic examinations,but the differences between the two groups did not reach significance. Howev-er, subgroup analyses demonstrated that Astragus therapy were effective in patients with moderate-ly severe cerebral infarction and those starting therapy within 24 hours after onset. Futher study of early therapy(starting therapy within 24 hours after onset)with Astragus and extending sam-ple size are justified.

关 键 词：黄芪 脑栓塞 急性 中医药疗法 

分 类 号：R277.733.3[医药卫生—中医学]